Zarlink Semiconductor Inc.
TSX : ZL
OTC Bulletin Board : ZARLF

Zarlink Semiconductor Inc.

September 08, 2010 09:30 ET

Zarlink Introduces Industry's Lowest Power, Highest Performance Radio Platform for Wireless Medical Devices

OTTAWA, CANADA--(Marketwire - Sept. 8, 2010) - Zarlink Semiconductor (TSX:ZL) 

  • Established and new customers deploying Zarlink's RF (radio frequency) platform in wireless medical devices to improve patient care and lower healthcare costs
  • Over typical seven year operating life, ultra low-power radio consumes the same amount of energy required to power a 40-watt light bulb for just 10 seconds

Zarlink Semiconductor (TSX:ZL) today announced that global medical device manufacturers are designing its new ultra low-power wireless radio platform into a broad range of in-body communication systems. Customers value Zarlink's ultra low-power radio technology, application support and quality expertise as they design wireless medical products supporting innovative monitoring, diagnostic and therapeutic applications to improve patient care and reduce healthcare costs. 

The ZL70102 MICS (Medical Implant Communication Services) radio platform is being designed into approved applications, including pacemakers, ICDs (implantable cardiac defibrillators), associated programming and home monitoring equipment, and new devices such as cardiac monitors and neuromodulation systems.

"The world's largest medical device manufacturers, as well as emerging companies introducing new technologies to the healthcare market, are deploying our ultra-low power radio platform in a wide range of applications and therapies that help improve patient care," said Kirk Mandy, President and CEO, Zarlink Semiconductor. "Our new MICS radio platform strengthens our medical business, by expanding our long-term relationships with customers seeking products that meet the unique performance and standards requirements for in-body communication systems."

Third Generation In-Body Wireless Technology

Zarlink's third-generation ZL70102 MICS radio platform delivers enhanced wake-up sensitivity over previous solutions to support an extended wireless link between implanted devices and monitoring and programming equipment. Zarlink's medical radio chips are the industry's only products designed exclusively to operate in the MICS 402-405 MHz frequency band.

Designed into wirelessly enabled pacemakers, Zarlink's radio chip routinely transmits patient health and device performance data to a home base station. Data is then forwarded to a physician's office. If a problem is detected, the physician schedules a follow-up visit and the two-way RF link is used to adjust device performance. Zarlink's ultra low-power RF technology is also enabling a new range of diagnostics and therapies, including implanted devices used to monitor and treat diabetes, manage chronic pain or lessen the effects of Parkinson's disease.

During surgery to implant medical devices, the extended wireless operating range of the ZL70102 MICS radio solution allows programming equipment to be located outside the sterile operating field. This potentially shortens surgery times and reduces healthcare costs.

The ZL70102 delivers advanced performance to help conserve battery life for wirelessly enabled implanted medical devices. The ZL70102 operates in an extremely low current "sleep mode" until communication is initiated by the base station. When in full operation, the ZL70102 consumes just 5 mA (milliamps) of supply current. Over a typical seven year operating life of an implanted medical device, the ZL70102 will consume the same amount of energy required to power a 40-watt light bulb for just 10 seconds.

"Our new ZL70102 radio platform solves key power and performance challenges for medical device manufacturers designing advanced in-body communication systems," said Steve Swift, Senior Vice President and General Manager of Zarlink's Medical Products Group. "Our expertise in developing high-performance, standards-compliant radio solutions that meet the unique quality standards for devices intended for human implant is helping our customers more easily incorporate wireless capabilities into existing and new devices and applications."

ZL70102 MICS radio platform available now

Zarlink's ZL70102 MICS radio platform is now available as a single-chip or complete implantable module solution. For information, visit http://www.zarlink.com/zarlink/hs/82_ZL102.htm

Full product information, including complete data sheets and application notes, is available to registered MyZarlink customers. To register for a MyZarlink account, visit http://www.zarlink.com/zarlink/hs/login.htm. To learn more about Zarlink's medical expertise, go to http://www.zarlink.com/zarlink/hs/Medical.htm.

Editor's Note: A high resolution photograph of the ZL70102 MICS radio platform is available at http://www.zarlink.com/zarlink/hs/22649.htm.

About Zarlink Semiconductor

Zarlink Semiconductor delivers world-leading, mixed-signal chip technologies for a broad range of communication and medical applications. The company's core capabilities include network timing solutions that manage time-sensitive communication applications over wireless and wired networks, line circuits supporting high-quality voice services over cable and broadband connections, and ultra low-power radios enabling new wireless medical devices and therapies. Serving the world's largest original equipment manufacturers, Zarlink's highly integrated chip solutions help customers simplify design, lower costs and reach market quickly. For more information, visit www.zarlink.com.

Shareholders and other individuals wishing to receive, free of charge, copies of the reports filed with the U.S. Securities and Exchange Commission and Regulatory Authorities, should visit the Company's web site at www.zarlink.com or contact Investor Relations.

Certain statements in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such risks, uncertainties and assumptions include, among others, the following: our dependence on the successful development and market introduction of new products; our ability to integrate any business, technologies, product lines or services that we have or will acquire; our dependence on revenue generation from our legacy products in order to fund development of our new products; current market conditions, including the lack of liquidity in the markets and economic slowdown, may increase our operating costs or reduce our revenue, thereby negatively impacting our operating results; our ability to operate profitably and generate positive cash flows in the future; the impact of the current economic crisis on our suppliers and customers and our ability to transfer parts to other suppliers; our dependence on our foundry suppliers and third-party subcontractors; order cancellations and deferrals by our customers; our substantial indebtedness could adversely affect our financial position; the cost and accounting implications of compliance with new accounting standards; and other factors referenced in our Annual Report on Form 20-F. Investors are encouraged to consider the risks detailed in this filing.

Zarlink and the Zarlink Semiconductor logo are trademarks of Zarlink Semiconductor Inc.

Contact Information